Dr. Heidi Overton Nominated to Lead FDA

Why it matters locally: Given Texas's significant agricultural sector and large pharmaceutical and medical device industries, the leadership of the FDA under Dr. Overton could directly influence regulatory frameworks affecting these key economic areas within the state. Decisions made by the FDA also impact public health policies and access to medications for Texas's 30.5 million residents.

President Trump has selected Dr. Heidi Overton as his nominee to lead the Food and Drug Administration (FDA). Dr. Overton currently serves as a policy aide within the White House. Upon confirmation, Dr. Overton would assume leadership of an agency comprising 18,000 staff members. The FDA's responsibilities include the study and regulation of food products, pharmaceutical drugs, medical devices, and tobacco products, among other areas. On August 10, Dr. Overton participated in a press conference where President Trump signed an executive order concerning the childhood vaccination schedule.